Noninvasive Prenatal Testing (NIPT) – Mom Guard
Germo - Mom Guard is a test that safely and accurately analyses the chromosomal numerical and some structural abnormalities of the fetus by using the fetal free DNA (cell free DNA) present in the pregnant woman's blood.
Non-invasive prenatal testing is SAFE
SIMPLE
Simple and Safe inspection
Since the test is performed using the mother's blood, it is a very safe test for both the mother and the fetus.
ACCURATE
High Accuracy
This test has an accuracy of over 99% compared to existing biochemical prenatal screening tests.
FAST
Early Detection
Testing is available from the 10th week of pregnancy, and results are available within 7 business days.
EFFICIENT
Simultaneous detection of numerical and structural chromosomal abnormalities
We test for representative chromosomal numerical abnormalities such as Down syndrome, Edward syndrome, Patau syndrome, and sex chromosome aneuploidy and structural abnormalities (microdeletions/microduplications).
Optional additional chromosomal abnormality analysis available with maternal consent
| Sample | Pregnant woman's blood, 8 mL or more, stored at room temperature |
|---|---|
| Inspection target | From 10 weeks of pregnancy |
| Inspection date | 7 Working days (based on business days) |
| Inspection method | Next-generation sequencing (NGS) |
Inspection items
| Test Name | Single Fetus | Twin Fetus |
|---|---|---|
| Germo - Momguard | 21, 18, 13 chromosome abnormalities | |
| Germo - Momguard Advanced |
|
21, 18, 13 chromosome abnormalities |
| Germo - Momguard Advanced Plus |
|
21, 18, 13, 9, 16, 22 chromosome abnormalities |
Sample Delivery Service
Sample pick up service is provided if requested by the customer.
Note
This test can only be requested through a medical institution, and it is important to consult with the specialist in charge before and after the test to clearly understand the test process and interpretation of the results.
This test is a screening test for fetal chromosomal abnormalities, and false positive and false negative results may occur. If a high-risk result is obtained, additional invasive tests (amniocentesis or chorionic villus sampling) are required for confirmation.
This test does not report on incidental findings that are discovered incidentally, regardless of the purpose of the test.
The analysis information from this test can only be used as reference material for the attending specialist, and no medical responsibility is assumed for false positive or false negative results.
This test is performed using a insured prescription drug.